Chemoinformaics analysis of 16-O-Methylcafestol
Molecular Weight | 330.468 | nRot | 2 |
Heavy Atom Molecular Weight | 300.228 | nRig | 23 |
Exact Molecular Weight | 330.219 | nRing | 5 |
Solubility: LogS | -3.562 | nHRing | 1 |
Solubility: LogP | 4.263 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 2 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 21 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
No. of Oxygen atom | 3 | No. of Arom Bond | 5 |
nHA | 3 | APOL | 57.4798 |
nHD | 1 | BPOL | 33.5682 |
QED | 0.879 |
Synth | 5.975 |
Natural Product Likeliness | 3.129 |
NR-PPAR-gamma | 0.103 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.003 |
Pgp-sub | 0.038 |
HIA | 0.003 |
CACO-2 | -5.142 |
MDCK | 0.00001 |
BBB | 0.101 |
PPB | 0.962488 |
VDSS | 1.371 |
FU | 0.0270115 |
CYP1A2-inh | 0.055 |
CYP1A2-sub | 0.709 |
CYP2c19-inh | 0.054 |
CYP2c19-sub | 0.846 |
CYP2c9-inh | 0.179 |
CYP2c9-sub | 0.276 |
CYP2d6-inh | 0.208 |
CYP2d6-sub | 0.834 |
CYP3a4-inh | 0.957 |
CYP3a4-sub | 0.491 |
CL | 12.236 |
T12 | 0.409 |
hERG | 0.428 |
Ames | 0.014 |
ROA | 0.894 |
SkinSen | 0.501 |
Carcinogencity | 0.551 |
EI | 0.018 |
Respiratory | 0.971 |
NR-Aromatase | 0.822 |
Antiviral | No |
Prediction | 0.712614 |